Manufacturer's investigation conclusion: the reported event could not be confirmed through this evaluation.Multiple attempts were made to obtain additional information from the customer regarding the event; however, no further information was provided.The explanted device was not returned for evaluation.The relevant sections of the device history records for (b)(4) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu) rev.C is currently available.Section 1, "introduction," lists device thrombosis as a potential adverse event which may be associated with the use of heartmate ii lvas.Section 6, ¿patient care and management¿ (under ¿anticoagulation¿), provides the recommended anticoagulation regimen, including international normalized ratio (inr) range, as well as suggested anticoagulation modifications.Section 1 and section 6 also outline indications of pump thrombosis and how to respond to such events.No further information was provided.The manufacturer is closing the file on this event.
|